Xie Shitong
-
Professional Title
Professor
Contact Information
- Zipcode：
- Postal Address：
- E-mail：
- Academic Achievements
Patents
No content
Books
Selected Papers
MORE+
- Shitong Xie. Cost effectiveness of brentuximab vedotin for relapsed or refractory classic Hodgkin lymphoma in China .Health Economics Review .2024 ,14
- Jiefu Wang, Tianqi Hong. Comparison of the Measurement Properties and Consistency between the EQ-5D-3L and EQ-5D-Y-3L in Adolescents Aged 15-17 in China .Health and Quality of Life Outcomes .2024 ,22
- Ling-Hsiang Chuang. Evaluating the Preferences and Willingness-to pay for Oral Antidiabetic Drug among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment .Patient - Patient Centered Outcomes Research .2024 ,17 :565–574
- Shitong Xie. The generic version of China Health Related Outcomes Measures (CHROME-G): Psychometric testing and comparative performance with the EQ-5D-5L and SF-6Dv2 among the Chinese general population .BMC Public Health .2024 ,24
- Shitong Xie. Eliciting and Anchoring Health State Preferences using Discrete Choice Experiments among Adults, Adolescents, and Children .PharmacoEconomics .2025 ,43 :1353–1366